138 related articles for article (PubMed ID: 875131)
1. [Course of prostate cancer under estrogen therapy].
Ducassou J; Richaud C; Hermanowicz M; Fiquet JM; Alimi JC
J Urol Nephrol (Paris); 1977; 83(1-2):91-9. PubMed ID: 875131
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy combined with hormone therapy for prostate cancer.
Tsuya A; Kawai T; Fukushima S; Shida K; Shimazaki J
Strahlentherapie; 1974 Jul; 148(1):24-34. PubMed ID: 4216125
[TBL] [Abstract][Full Text] [Related]
3. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
4. The choice of estrogen preparations in the treatment of prostatic cancer.
Morales A; Pujari B
Can Med Assoc J; 1975 Nov; 113(9):865-7. PubMed ID: 1182631
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
[TBL] [Abstract][Full Text] [Related]
6. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
7. Preoperative endocrine therapy in patients with locally advanced prostate cancer.
Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Jpn J Clin Oncol; 1995 Aug; 25(4):135-9. PubMed ID: 7545250
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stage IV carcinoma of the prostate.
Resnick MI; Grayhack JT
Urol Clin North Am; 1975 Feb; 2(1):141-61. PubMed ID: 1093057
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen therapy on metastatic carcinoma of the prostate.
Anikwe RM
Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the prostate. II.
Fergusson JD
Br Med J; 1970 Nov; 4(5734):539-40. PubMed ID: 5483325
[No Abstract] [Full Text] [Related]
12. [Functional state of the adrenal cortex in cancer and adenoma of the prostate in the process of estrogen therapy].
Klepikov FA; Genes SG; Popova SS
Urol Nefrol (Mosk); 1972; 37(6):38-42. PubMed ID: 4124660
[No Abstract] [Full Text] [Related]
13. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of clinically localized prostatic cancer--endocrine therapy].
Hirano A
Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
[TBL] [Abstract][Full Text] [Related]
15. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
Scherr DS; Pitts WR
J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?
Karlsson CT; Malmer B; Wiklund F; Grönberg H
J Urol; 2006 Aug; 176(2):538-43. PubMed ID: 16813884
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
18. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
Labrie F; Dupont A; Cusan L; Gomez J; Diamond P; Koutsilieris M; Suburu R; Fradet Y; Lemay M; Têtu B
Clin Invest Med; 1993 Dec; 16(6):499-509. PubMed ID: 8013155
[TBL] [Abstract][Full Text] [Related]
19. [Hormone therapy in carcinoma of the prostate].
Marberger H
Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
[No Abstract] [Full Text] [Related]
20. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
